The role of DNA methylation in the pathophysiology and treatment of bipolar disorder

Neuroscience and Biobehavioral Reviews

Volumn 68, Issue , 2016, Pages 474-488

  Fries, Gabriel R ^a   Li, Qiongzhen ^a   McAlpin, Blake ^a   Rein, Theo ^b   Walss Bass, Consuelo ^a,c   Soares, Jair C ^a   Quevedo, Joao ^a,c,d  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Bipolar disorder; Depression; DNA methylation; DNA methyltransferase; Epigenetics; Mood disorders; Mood stabilizers

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARBAMAZEPINE; DYSBINDIN; LITHIUM; MOOD STABILIZER; POTASSIUM CHANNEL KCNQ3; REELIN; VALPROIC ACID;

BDNF GENE; BIPOLAR DISORDER; DISEASE ASSOCIATION; DNA METHYLATION; DRUG MECHANISM; DTNBP1 GENE; FAM63B GENE; FKBP5 GENE; GAD1 GENE; GENE; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENOTYPE ENVIRONMENT INTERACTION; HCG9 GENE; HUMAN; KCNQ3 GENE; MB COMT GENE; PATHOPHYSIOLOGY; PATIENT CARE; PPIEL GENE; PRIORITY JOURNAL; PROGNOSIS; REELIN GENE; REVIEW; RGS4 GENE; RISK FACTOR; SEROTONINERGIC SYSTEM; GENE EXPRESSION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION;

BIPOLAR DISORDER; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84976563077     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2016.06.010     Document Type: Review

References (144)

1. Abdolmaleky, H.M., Cheng, K.H., Faraone, S.V., Wilcox, M., Glatt, S.J., Gao, F., Smith, C.L., Shafa, R., Aeali, B., Carnevale, J., Pan, H., Papageorgis, P., Ponte, J.F., Sivaraman, V., Tsuang, M.T., Thiagalingam, S., Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15 (2006), 3132–3145.
2. Abdolmaleky, H.M., Nohesara, S., Ghadirivasfi, M., Lambert, A.W., Ahmadkhaniha, H., Ozturk, S., Wong, C.K., Shafa, R., Mostafavi, A., Thiagalingam, S., DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia. Schizophr. Res. 152 (2014), 373–380.
3. Abdolmaleky, H.M., Pajouhanfar, S., Faghankhani, M., Joghataei, M.T., Mostafavi, A., Thiagalingam, S., Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 168 (2015), 687–696.
4. Abdolmaleky, H.M., Yaqubi, S., Papageorgis, P., Lambert, A.W., Ozturk, S., Sivaraman, V., Thiagalingam, S., Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder. Schizophr. Res. 129 (2011), 183–190.
5. Aberg, K.A., McClay, J.L., Nerella, S., Clark, S., Kumar, G., Chen, W., Khachane, A.N., Xie, L., Hudson, A., Gao, G., Harada, A., Hultman, C.M., Sullivan, P.F., Magnusson, P.K., van den Oord, E.J., Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry 71 (2014), 255–264.
6. Aizawa, S., Yamamuro, Y., Valproate administration to mice increases hippocampal p21 expression by altering genomic DNA methylation. Neuroreport 26 (2015), 915–920.
7. Anand, A., Koller, D.L., Lawson, W.B., Gershon, E.S., Nurnberger, J.I., Genetic and childhood trauma interaction effect on age of onset in bipolar disorder: an exploratory analysis. J. Affect. Disord. 179 (2015), 1–5.
8. Asai, T., Bundo, M., Sugawara, H., Sunaga, F., Ueda, J., Tanaka, G., Ishigooka, J., Kasai, K., Kato, T., Iwamoto, K., Effect of mood stabilizers on DNA methylation in human neuroblastoma cells. Int J. Neuropsychopharmacol. 16 (2013), 2285–2294.
9. Binder, E.B., Salyakina, D., Lichtner, P., Wochnik, G.M., Ising, M., Putz, B., Papiol, S., Seaman, S., Lucae, S., Kohli, M.A., Nickel, T., Kunzel, H.E., Fuchs, B., Majer, M., Pfennig, A., Kern, N., Brunner, J., Modell, S., Baghai, T., Deiml, T., Zill, P., Bondy, B., Rupprecht, R., Messer, T., Kohnlein, O., Dabitz, H., Bruckl, T., Muller, N., Pfister, H., Lieb, R., Mueller, J.C., Lohmussaar, E., Strom, T.M., Bettecken, T., Meitinger, T., Uhr, M., Rein, T., Holsboer, F., Muller-Myhsok, B., Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 36 (2004), 1319–1325.
10. Bockmuhl, Y., Patchev, A.V., Madejska, A., Hoffmann, A., Sousa, J.C., Sousa, N., Holsboer, F., Almeida, O.F., Spengler, D., Methylation at the CpG island shore region upregulates Nr3c1 promoter activity after early-life stress. Epigenetics 10 (2015), 247–257.
11. Breiling, A., Lyko, F., Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenet. Chromatin, 8, 2015, 24.
12. Brietzke, E., Kauer Sant'anna, M., Jackowski, A., Grassi-Oliveira, R., Bucker, J., Zugman, A., Mansur, R.B., Bressan, R.A., Impact of Childhood Stress on Psychopathology, 34, 2012, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, 480–488 (1999).
13. Bromberg, A., Bersudsky, Y., Levine, J., Agam, G., Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J. Affect. Disord. 118 (2009), 234–239.
14. Burghardt, K.J., Goodrich, J.M., Dolinoy, D.C., Ellingrod, V.L., DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder. Epigenomics 7 (2015), 343–352.
15. Carlberg, L., Scheibelreiter, J., Hassler, M.R., Schloegelhofer, M., Schmoeger, M., Ludwig, B., Kasper, S., Aschauer, H., Egger, G., Schosser, A., Brain-derived neurotrophic factor (BDNF)-epigenetic regulation in unipolar and bipolar affective disorder. J. Affect. Disord. 168 (2014), 399–406.
16. Carrard, A., Salzmann, A., Malafosse, A., Karege, F., Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. J. Affect. Disord. 132 (2011), 450–453.
17. Carvalho, A.F., Kohler, C.A., Fernandes, B.S., Quevedo, J., Miskowiak, K.W., Brunoni, A.R., Machado-Vieira, R., Maes, M., Vieta, E., Berk, M., Bias in emerging biomarkers for bipolar disorder. Psychol. Med., 2016, 1–11.
18. Chen, C., Zhang, C., Cheng, L., Reilly, J.L., Bishop, J.R., Sweeney, J.A., Chen, H.Y., Gershon, E.S., Liu, C., Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia. Bipolar Disord. 16 (2014), 790–799.
19. Clark, C., Palta, P., Joyce, C.J., Scott, C., Grundberg, E., Deloukas, P., Palotie, A., Coffey, A.J., A comparison of the whole genome approach of MeDIP-seq to the targeted approach of the Infinium HumanMethylation450 BeadChip((R)) for methylome profiling. PLoS One, 7, 2012, e50233.
20. Cortazar, D., Kunz, C., Selfridge, J., Lettieri, T., Saito, Y., MacDougall, E., Wirz, A., Schuermann, D., Jacobs, A.L., Siegrist, F., Steinacher, R., Jiricny, J., Bird, A., Schar, P., Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 470 (2011), 419–423.
21. Corvin, A., Donohoe, G., Nangle, J.M., Schwaiger, S., Morris, D., Gill, M., A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis. Neurosci. Lett. 431 (2008), 146–149.
22. D'Addario, C., Dell'Osso, B., Palazzo, M.C., Benatti, B., Lietti, L., Cattaneo, E., Galimberti, D., Fenoglio, C., Cortini, F., Scarpini, E., Arosio, B., Di Francesco, A., Di Benedetto, M., Romualdi, P., Candeletti, S., Mari, D., Bergamaschini, L., Bresolin, N., Maccarrone, M., Altamura, A.C., Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 37 (2012), 1647–1655.
23. Davies, M.N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R.A., Milosavljevic, A., Troakes, C., Al-Sarraj, S., Dobson, R., Schalkwyk, L.C., Mill, J., Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol., 13, 2012, R43.
24. Dell'Osso, B., D'Addario, C., Carlotta Palazzo, M., Benatti, B., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E., Di Francesco, A., Maccarrone, M., Altamura, A.C., Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J. Affect. Disord. 166 (2014), 330–333.
25. Dempster, E.L., Pidsley, R., Schalkwyk, L.C., Owens, S., Georgiades, A., Kane, F., Kalidindi, S., Picchioni, M., Kravariti, E., Toulopoulou, T., Murray, R.M., Mill, J., Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20 (2011), 4786–4796.
26. Ding, L., Hegde, A.N., Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients. Biol. Psychiatry 65 (2009), 541–545.
27. Ding, L., Styblo, M., Drobna, Z., Hegde, A.N., Expression of the longest RGS4 splice variant in the prefrontal cortex is associated with single nucleotide polymorphisms in schizophrenia patients. Front. Psychiatry, 7, 2016, 26.
28. Dobosy, J.R., Selker, E.U., Emerging connections between DNA methylation and histone acetylation. Cell. Mol. Life Sci. 58 (2001), 721–727.
29. Domschke, K., Lawford, B., Young, R., Voisey, J., Morris, C.P., Roehrs, T., Hohoff, C., Birosova, E., Arolt, V., Baune, B.T., Dysbindin (DTNBP1)—a role in psychotic depression. J. Psychiatr. Res. 45 (2011), 588–595.
30. Dong, E., Nelson, M., Grayson, D.R., Costa, E., Guidotti, A., Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 13614–13619.
31. Dong, E., Ruzicka, W.B., Grayson, D.R., Guidotti, A., DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients. Schizophr. Res. 167 (2015), 35–41.
32. Du, Q., Luu, P.L., Stirzaker, C., Clark, S.J., Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 7 (2015), 1051–1073.
33. Dunn, E.C., Brown, R.C., Dai, Y., Rosa, J., Nugent, N.R., Amstadter, A.B., Smoller, J.W., Genetic determinants of depression: recent findings and future directions. Harv. Rev. Psychiatry 23 (2015), 1–18.
34. Dwivedi, T., Zhang, H., Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins. Front. Neurosci., 8, 2014, 457.
35. Egan, M.F., Kojima, M., Callicott, J.H., Goldberg, T.E., Kolachana, B.S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., Lu, B., Weinberger, D.R., The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112 (2003), 257–269.
36. Erdmann, A., Halby, L., Fahy, J., Arimondo, P.B., Targeting DNA methylation with small molecules: what's next?. J. Med. Chem. 58 (2015), 2569–2583.
37. Fatemi, S.H., Earle, J.A., McMenomy, T., Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 5 (2000), 654–663 (571).
38. Fatemi, S.H., Reelin, a marker of stress resilience in depression and psychosis. Neuropsychopharmacology 36 (2011), 2371–2372.
39. Frauer, C., Rottach, A., Meilinger, D., Bultmann, S., Fellinger, K., Hasenoder, S., Wang, M., Qin, W., Soding, J., Spada, F., Leonhardt, H., Different binding properties and function of CXXC zinc finger domains in Dnmt1 and Tet1. PLoS One, 6, 2011, e16627.
40. Frey, B.N., Andreazza, A.C., Houenou, J., Jamain, S., Goldstein, B.I., Frye, M.A., Leboyer, M., Berk, M., Malhi, G.S., Lopez-Jaramillo, C., Taylor, V.H., Dodd, S., Frangou, S., Hall, G.B., Fernandes, B.S., Kauer-Sant'Anna, M., Yatham, L.N., Kapczinski, F., Young, L.T., Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust. N. Z. J. Psychiatry 47 (2013), 321–332.
41. Fries, G.R., Gassen, N.C., Schmidt, U., Rein, T., The FKBP51-glucocorticoid receptor balance in stress-related mental disorders. Curr. Mol. Pharmacol. 9 (2015), 126–140.
42. Fries, G.R., Vasconcelos-Moreno, M.P., Gubert, C., dos Santos, B.T., Sartori, J., Eisele, B., Ferrari, P., Fijtman, A., Rüegg, J., Gassen, N.C., Kapczinski, F., Rein, T., Kauer-Sant'Anna, M., Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder. Int. J. Neuropsychopharmacol., 31, 2015, 18.
43. Fries, G.R., Quevedo, J., Soares, J.C., Walss-Bass, C., Genome-wide expression and methylation analyses in pediatric bipolar disorder and high-risk offspring: a preliminary study. Biol. Psychiatry, 79, 2016, 229S.
44. Gassen, N.C., Hartmann, J., Zschocke, J., Stepan, J., Hafner, K., Zellner, A., Kirmeier, T., Kollmannsberger, L., Wagner, K.V., Dedic, N., Balsevich, G., Deussing, J.M., Kloiber, S., Lucae, S., Holsboer, F., Eder, M., Uhr, M., Ising, M., Schmidt, M.V., Rein, T., Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS Med., 11, 2014, e1001755.
45. Gassen, N.C., Fries, G.R., Zannas, A.S., Hartmann, J., Zschocke, J., Hafner, K., Carrillo-Roa, T., Steinbacher, J., Preissinger, S.N., Hoeijmakers, L., Knop, M., Weber, F., Kloiber, S., Lucae, S., Chrousos, G.P., Carell, T., Ising, M., Binder, E.B., Schmidt, M.V., Ruegg, J., Rein, T., Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Sci. Signal., 8, 2015, ra119.
46. Gassen, N.C., Hartmann, J., Zannas, A.S., Kretzschmar, A., Zschocke, J., Maccarrone, G., Hafner, K., Zellner, A., Kollmannsberger, L.K., Wagner, K.V., Mehta, D., Kloiber, S., Turck, C.W., Lucae, S., Chrousos, G.P., Holsboer, F., Binder, E.B., Ising, M., Schmidt, M.V., Rein, T., FKBP51 inhibits GSK3beta and augments the effects of distinct psychotropic medications. Mol. Psychiatry 21 (2015), 277–289.
47. Ghadirivasfi, M., Nohesara, S., Ahmadkhaniha, H.R., Eskandari, M.R., Mostafavi, S., Thiagalingam, S., Abdolmaleky, H.M., Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 156b (2011), 536–545.
48. Glatt, S.J., Chandler, S.D., Bousman, C.A., Chana, G., Lucero, G.R., Tatro, E., May, T., Lohr, J.B., Kremen, W.S., Everall, I.P., Tsuang, M.T., Alternatively spliced genes as biomarkers for schizophrenia, bipolar disorder and psychosis: a blood-based spliceome-profiling exploratory study. Curr. Pharmacogenomics Pers. Med. 7 (2009), 164–188.
49. Glatt, S.J., Cohen, O.S., Faraone, S.V., Tsuang, M.T., Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 156b (2011), 382–392.
50. Grande, I., Berk, M., Birmaher, B., Vieta, E., Bipolar disorder. Lancet 387 (2016), 1561–1572.
51. Guidotti, A., Grayson, D.R., DNA methylation and demethylation as targets for antipsychotic therapy. Dialogues Clin. Neurosci. 16 (2014), 419–429.
52. Guidotti, A., Auta, J., Davis, J.M., Di-Giorgi-Gerevini, V., Dwivedi, Y., Grayson, D.R., Impagnatiello, F., Pandey, G., Pesold, C., Sharma, R., Uzunov, D., Costa, E., Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000), 1061–1069.
53. Guidotti, A., Ruzicka, W., Grayson, D.R., Veldic, M., Pinna, G., Davis, J.M., Costa, E., S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18 (2007), 57–60.
54. Guidotti, A., Dong, E., Gavin, D.P., Veldic, M., Zhao, W., Bhaumik, D.K., Pandey, S.C., Grayson, D.R., DNA methylation/demethylation network expression in psychotic patients with a history of alcohol abuse. Alcohol. Clin. Exp. Res. 37 (2013), 417–424.
55. Guidotti, A., Grayson, D.R., Caruncho, H.J., Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders. Front. Cell. Neurosci., 10, 2016, 89.
56. Higuchi, F., Uchida, S., Yamagata, H., Otsuki, K., Hobara, T., Abe, N., Shibata, T., Watanabe, Y., State-dependent changes in the expression of DNA methyltransferases in mood disorder patients. J. Psychiatr. Res. 45 (2011), 1295–1300.
57. Hong, C.J., Liou, Y.J., Tsai, S.J., Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res. Bull. 86 (2011), 287–297.
58. Horvath, S., Zhang, Y., Langfelder, P., Kahn, R.S., Boks, M.P., van Eijk, K., van den Berg, L.H., Ophoff, R.A., Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol., 13, 2012, R97.
59. Hosang, G.M., Uher, R., Keers, R., Cohen-Woods, S., Craig, I., Korszun, A., Perry, J., Tozzi, F., Muglia, P., McGuffin, P., Farmer, A.E., Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder. J. Affect. Disord. 125 (2010), 345–349.
60. Houtepen, L.C., van Bergen, A.H., Vinkers, C.H., Boks, M.P., DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Epigenomics 8 (2016), 197–208.
61. Huzayyin, A.A., Andreazza, A.C., Turecki, G., Cruceanu, C., Rouleau, G.A., Alda, M., Young, L.T., Decreased global methylation in patients with bipolar disorder who respond to lithium. Int. J. Neuropsychopharmacol. 17 (2014), 561–569.
62. Jann, M.W., Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments. Am. Health Drug Benefits 7 (2014), 489–499.
63. Joo, E.J., Lee, K.Y., Jeong, S.H., Chang, J.S., Ahn, Y.M., Koo, Y.J., Kim, Y.S., Dysbindin gene variants are associated with bipolar I disorder in a Korean population. Neurosci. Lett. 418 (2007), 272–275.
64. Kaminsky, Z., Tochigi, M., Jia, P., Pal, M., Mill, J., Kwan, A., Ioshikhes, I., Vincent, J.B., Kennedy, J.L., Strauss, J., Pai, S., Wang, S.C., Petronis, A., A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder. Mol. Psychiatry 17 (2012), 728–740.
65. Kaminsky, Z., Jones, I., Verma, R., Saleh, L., Trivedi, H., Guintivano, J., Akman, R., Zandi, P., Lee, R.S., Potash, J.B., DNA methylation and expression of KCNQ3 in bipolar disorder. Bipolar Disord. 17 (2015), 150–159.
66. Karatsoreos, I.N., Links between circadian rhythms and psychiatric disease. Front. Behav. Neurosci., 8, 2014, 162.
67. Kerner, B., Toward a deeper understanding of the genetics of bipolar disorder. Front. Psychiatry, 6, 2015, 105.
68. Klengel, T., Mehta, D., Anacker, C., Rex-Haffner, M., Pruessner, J.C., Pariante, C.M., Pace, T.W., Mercer, K.B., Mayberg, H.S., Bradley, B., Nemeroff, C.B., Holsboer, F., Heim, C.M., Ressler, K.J., Rein, T., Binder, E.B., Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 16 (2013), 33–341.
69. Klengel, T., Dias, B.G., Ressler, K.J., Models of intergenerational and transgenerational transmission of risk for psychopathology in mice. Neuropsychopharmacology 41 (2016), 219–231.
70. Klengel, T., Howell, B., Guzman, D., Morin, E., Binder, E.B., Ressler, K.J., Sanchez, M., Intergenerational effects of infant maltreatment on epigenetic and functional outcomes in rhesus monkeys. Biol. Psychiatry, 79, 2016, 143S.
71. Klose, R.J., Bird, A.P., Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31 (2006), 89–97.
72. Kouzarides, T., Chromatin modifications and their function. Cell 128 (2007), 693–705.
73. Kozlenkov, A., Wang, M., Roussos, P., Rudchenko, S., Barbu, M., Bibikova, M., Klotzle, B., Dwork, A.J., Zhang, B., Hurd, Y.L., Koonin, E.V., Wegner, M., Dracheva, S., Substantial DNA methylation differences between two major neuronal subtypes in human brain. Nucleic Acids Res. 44 (2016), 2593–2612.
74. Kulis, M., Queiros, A.C., Beekman, R., Martin-Subero, J.I., Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer. Biochim. Biophys. Acta 1829 (2013), 1161–1174.
75. Kuratomi, G., Iwamoto, K., Bundo, M., Kusumi, I., Kato, N., Iwata, N., Ozaki, N., Kato, T., Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 13 (2008), 429–441.
76. Lee, R.S., Pirooznia, M., Guintivano, J., Ly, M., Ewald, E.R., Tamashiro, K.L., Gould, T.D., Moran, T.H., Potash, J.B., Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene. Transl. Psychiatry, 5, 2015, e600.
77. Lev Maor, G., Yearim, A., Ast, G., The alternative role of DNA methylation in splicing regulation. Trends Genet. 31 (2015), 274–280.
78. Li, Y., Camarillo, C., Xu, J., Arana, T.B., Xiao, Y., Zhao, Z., Chen, H., Ramirez, M., Zavala, J., Escamilla, M.A., Armas, R., Mendoza, R., Ontiveros, A., Nicolini, H., Magana, A.A., Rubin, L.P., Li, X., Xu, C., Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder. BioMed Res. Int., 2015, 2015, 201587.
79. Lisanti, S., Omar, W.A., Tomaszewski, B., De Prins, S., Jacobs, G., Koppen, G., Mathers, J.C., Langie, S.A., Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS One, 8, 2013, e79044.
80. Lister, R., Mukamel, E.A., Turning over DNA methylation in the mind. Front. Neurosci., 9, 2015, 252.
81. Liu, J., Chen, J., Ehrlich, S., Walton, E., White, T., Perrone-Bizzozero, N., Bustillo, J., Turner, J.A., Calhoun, V.D., Methylation patterns in whole blood correlate with symptoms in schizophrenia patients. Schizophr. Bull. 40 (2014), 769–776.
82. Liu, J., Siyahhan Julnes, P., Chen, J., Ehrlich, S., Walton, E., Calhoun, V.D., The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients. Schizophr. Res. 169 (2015), 447–452.
83. Lo, R., Weksberg, R., Biological and biochemical modulation of DNA methylation. Epigenomics 6 (2014), 593–602.
84. Malhi, G.S., Tanious, M., Das, P., Coulston, C.M., Berk, M., Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS drugs 27 (2013), 135–153.
85. Maunakea, A.K., Nagarajan, R.P., Bilenky, M., Ballinger, T.J., D'Souza, C., Fouse, S.D., Johnson, B.E., Hong, C., Nielsen, C., Zhao, Y., Turecki, G., Delaney, A., Varhol, R., Thiessen, N., Shchors, K., Heine, V.M., Rowitch, D.H., Xing, X., Fiore, C., Schillebeeckx, M., Jones, S.J., Haussler, D., Marra, M.A., Hirst, M., Wang, T., Costello, J.F., Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466 (2010), 253–257.
86. Menke, A., Binder, E.B., Epigenetic alterations in depression and antidepressant treatment. Dialogues Clin. Neurosci. 16 (2014), 395–404.
87. Mill, J., Tang, T., Kaminsky, Z., Khare, T., Yazdanpanah, S., Bouchard, L., Jia, P., Assadzadeh, A., Flanagan, J., Schumacher, A., Wang, S.C., Petronis, A., Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82 (2008), 696–711.
88. Milutinovic, S., D'Alessio, A.C., Detich, N., Szyf, M., Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 28 (2007), 560–571.
89. Mirnics, K., Middleton, F.A., Stanwood, G.D., Lewis, D.A., Levitt, P., Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 6 (2001), 293–301.
90. Nestler, E.J., Pena, C.J., Kundakovic, M., Mitchell, A., Akbarian, S., Epigenetic basis of mental illness. The neuroscientist: a review journal bringing neurobiology. Neurol. Psychiatry, 2015.
91. Nohesara, S., Ghadirivasfi, M., Mostafavi, S., Eskandari, M.R., Ahmadkhaniha, H., Thiagalingam, S., Abdolmaleky, H.M., DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J. Psychiatr. Res. 45 (2011), 1432–1438.
92. Oliveira, J., Etain, B., Lajnef, M., Hamdani, N., Bennabi, M., Bengoufa, D., Sundaresh, A., Chaabane, A.B., Bellivier, F., Henry, C., Kahn, J.P., Charron, D., Krishnamoorthy, R., Leboyer, M., Tamouza, R., Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders. PLoS One, 10, 2015, e0119702.
93. Oliveira, J., Kazma, R., Le Floch, E., Bennabi, M., Hamdani, N., Bengoufa, D., Dahoun, M., Manier, C., Bellivier, F., Krishnamoorthy, R., Deleuze, J.F., Yolken, R., Leboyer, M., Tamouza, R., Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study. Int. J. Bipolar Disord., 4, 2016, 11.
94. Ovadia, G., Shifman, S., The genetic variation of RELN expression in schizophrenia and bipolar disorder. PLoS One, 6, 2011, e19955.
95. Pal, M., Ebrahimi, S., Oh, G., Khare, T., Zhang, A., Kaminsky, Z.A., Wang, S.C., Petronis, A., High precision DNA modification analysis of HCG9 in major psychosis. Schizophr. Bull. 42 (2016), 170–177.
96. Perisic, T., Zimmermann, N., Kirmeier, T., Asmus, M., Tuorto, F., Uhr, M., Holsboer, F., Rein, T., Zschocke, J., Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology 35 (2010), 792–805.
97. Perroud, N., Zewdie, S., Stenz, L., Adouan, W., Bavamian, S., Prada, P., Nicastro, R., Hasler, R., Nallet, A., Piguet, C., Paoloni-Giacobino, A., Aubry, J.M., Dayer, A., Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress. Anxiety 33 (2016), 45–55.
98. Phiel, C.J., Zhang, F., Huang, E.Y., Guenther, M.G., Lazar, M.A., Klein, P.S., Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276 (2001), 36734–36741.
99. Polesskaya, O.O., Aston, C., Sokolov, B.P., Allele C-specific methylation of the 5-HT2A receptor gene: evidence for correlation with its expression and expression of DNA methylase DNMT1. J. Neurosci. Res. 83 (2006), 362–373.
100. Popkie, A.P., Zeidner, L.C., Albrecht, A.M., D'Ippolito, A., Eckardt, S., Newsom, D.E., Groden, J., Doble, B.W., Aronow, B., McLaughlin, K.J., White, P., Phiel, C.J., Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci. J. Biol. Chem. 285 (2010), 41337–41347.
101. Potash, J.B., DePaulo, J.R. Jr., Searching high and low: a review of the genetics of bipolar disorder. Bipolar Disord. 2 (2000), 8–26.
102. Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., Timmusk, T., Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 90 (2007), 397–406.
103. Rao, J.S., Keleshian, V.L., Klein, S., Rapoport, S.I., Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl. Psychiatry, 2, 2012, e132.
104. Rao, J.S., Kellom, M., Reese, E.A., Rapoport, S.I., Kim, H.W., Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J. Affect. Disord. 136 (2012), 63–71.
105. Reddington, J.P., Pennings, S., Meehan, R.R., Non-canonical functions of the DNA methylome in gene regulation. Biochem. J. 451 (2013), 13–23.
106. Rice, F., Harold, G., Thapar, A., The genetic aetiology of childhood depression: a review. J. Child Psychol. Psychiatry 43 (2002), 65–79.
107. Rosa, A., Picchioni, M.M., Kalidindi, S., Loat, C.S., Knight, J., Toulopoulou, T., Vonk, R., van der Schot, A.C., Nolen, W., Kahn, R.S., McGuffin, P., Murray, R.M., Craig, I.W., Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am. J. Med. Genet. B Neuro Psychiatr. Genet. 147B (2008), 459–462.
108. Roundtree, I.A., He, C., RNA epigenetics-chemical messages for posttranscriptional gene regulation. Curr. Opin. Chem. Biol. 30 (2015), 46–51.
109. Ruzicka, W.B., Subburaju, S., Benes, F.M., Circuit- and diagnosis-specific DNA methylation changes at gamma-aminobutyric acid-related genes in postmortem human hippocampus in schizophrenia and bipolar disorder. JAMA Psychiatry 72 (2015), 541–551.
110. Sabunciyan, S., Maher, B., Bahn, S., Dickerson, F., Yolken, R.H., Association of DNA methylation with acute mania and inflammatory markers. PLoS One, 10, 2015, e0132001.
111. Sadakierska-Chudy, A., Kostrzewa, R.M., Filip, M., A comprehensive view of the epigenetic landscape part I: DNA methylation, passive and active DNA demethylation pathways and histone variants. Neurotox. Res. 27 (2015), 84–97.
112. Sales, A.J., Joca, S.R., Effects of DNA methylation inhibitors and conventional antidepressants on mice behaviour and brain DNA methylation levels. Acta Neuropsychiatr. 28 (2016), 11–22.
113. Sales, A.J., Biojone, C., Terceti, M.S., Guimaraes, F.S., Gomes, M.V., Joca, S.R., Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors. Br. J. Pharmacol. 164 (2011), 1711–1721.
114. Schubeler, D., Function and information content of DNA methylation. Nature 517 (2015), 321–326.
115. Scola, G., Kim, H.K., Young, L.T., Salvador, M., Andreazza, A.C., Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons. Psychopharmacology (Berl) 231 (2014), 4189–4198.
116. Simmer, F., Brinkman, A.B., Assenov, Y., Matarese, F., Kaan, A., Sabatino, L., Villanueva, A., Huertas, D., Esteller, M., Lengauer, T., Bock, C., Colantuoni, V., Altucci, L., Stunnenberg, H.G., Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues. Epigenetics 7 (2012), 1355–1367.
117. Smith, A.K., Kilaru, V., Klengel, T., Mercer, K.B., Bradley, B., Conneely, K.N., Ressler, K.J., Binder, E.B., DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 168b (2015), 36–44.
118. Smoller, J.W., Finn, C.T., Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet.: C Semin. Med. Genet. 123c (2003), 48–58.
119. Soeiro-de-Souza, M.G., Andreazza, A.C., Carvalho, A.F., Machado-Vieira, R., Young, L.T., Moreno, R.A., Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder. Int. J. Neuropsychopharmacol. 16 (2013), 1505–1512.
120. Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W., Bauer, C., Munzel, M., Wagner, M., Muller, M., Khan, F., Eberl, H.C., Mensinga, A., Brinkman, A.B., Lephikov, K., Muller, U., Walter, J., Boelens, R., van Ingen, H., Leonhardt, H., Carell, T., Vermeulen, M., Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152 (2013), 1146–1159.
121. Starnawska, A., Demontis, D., McQuillin, A., O'Brien, N.L., Staunstrup, N.H., Mors, O., Nielsen, A.L., Borglum, A.D., Nyegaard, M., Hypomethylation of FAM63B in bipolar disorder patients. Clin. Epigenet., 8, 2016, 52.
122. Stenz, L., Zewdie, S., Laforge-Escarra, T., Prados, J., La Harpe, R., Dayer, A., Paoloni-Giacobino, A., Perroud, N., Aubry, J.M., BDNF promoter I methylation correlates between post-mortem human peripheral and brain tissues. Neurosci. Res. 91 (2015), 1–7.
123. Strauss, J.S., Khare, T., De Luca, V., Jeremian, R., Kennedy, J.L., Vincent, J.B., Petronis, A., Quantitative leukocyte BDNF promoter methylation analysis in bipolar disorder. Int. J. Bipolar Disord., 1, 2013, 28.
124. Sugawara, H., Iwamoto, K., Bundo, M., Ueda, J., Miyauchi, T., Komori, A., Kazuno, A., Adati, N., Kusumi, I., Okazaki, Y., Ishigooka, J., Kojima, T., Kato, T., Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins. Transl. Psychiatry, 1, 2011, e24.
125. Sullivan, P.F., Neale, M.C., Kendler, K.S., Genetic epidemiology of major depression: review and meta-analysis. Am. J. Psychiatry 157 (2000), 1552–1562.
126. Szyf, M., The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation. Toxicol. Sci. 120 (2011), 235–255.
127. Tamura, Y., Kunugi, H., Ohashi, J., Hohjoh, H., Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 12:519 (2007), 593–600.
128. Teroganova, N., Girshkin, L., Suter, C.M., Green, M.J., DNA methylation in peripheral tissue of schizophrenia and bipolar disorder: a systematic review. BMC Genet., 17, 2016, 27.
129. Tognini, P., Napoli, D., Pizzorusso, T., Dynamic DNA methylation in the brain: a new epigenetic mark for experience-dependent plasticity. Front. Cell. Neurosci., 9, 2015, 331.
130. Veldic, M., Guidotti, A., Maloku, E., Davis, J.M., Costa, E., In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 2152–2157.
131. Veldic, M., Kadriu, B., Maloku, E., Agis-Balboa, R.C., Guidotti, A., Davis, J.M., Costa, E., Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr. Res. 91 (2007), 51–61.
132. Walker, R.M., Christoforou, A.N., McCartney, D.L., Morris, S.W., Kennedy, N.A., Morten, P., Anderson, S.M., Torrance, H.S., Macdonald, A., Sussmann, J.E., Whalley, H.C., Blackwood, D.H., McIntosh, A.M., Porteous, D.J., Evans, K.L., DNA methylation in a Scottish family multiply affected by bipolar disorder and major depressive disorder. Clin. Epigenet., 8, 2016, 5.
133. Walton, E., Hass, J., Liu, J., Roffman, J.L., Bernardoni, F., Roessner, V., Kirsch, M., Schackert, G., Calhoun, V., Ehrlich, S., Correspondence of DNA methylation between blood and brain tissue and its application to schizophrenia research. Schizophr. Bull. 42 (2016), 406–414.
134. Weber-Stadlbauer, U., Richetto, J., Labouesse, M.A., Bohacek, J., Mansuy, I.M., Meyer, U., Transgenerational transmission and modification of pathological traits induced by prenatal immune activation. Mol. Psychiatry, 2016, 10.1038/mp.2016.41 (in press).
135. Wen, L., Tang, F., Genomic distribution and possible functions of DNA hydroxymethylation in the brain. Genomics 104 (2014), 341–346.
136. Wochnik, G.M., Ruegg, J., Abel, G.A., Schmidt, U., Holsboer, F., Rein, T., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J. Biol. Chem. 280 (2005), 4609–4616.
137. Wu, R., Fan, J., Zhao, J., Calabrese, J.R., Gao, K., The relationship between neurotrophins and bipolar disorder. Expert Rev. Neurother. 14 (2014), 51–65.
138. Xiao, Y., Camarillo, C., Ping, Y., Arana, T.B., Zhao, H., Thompson, P.M., Xu, C., Su, B.B., Fan, H., Ordonez, J., Wang, L., Mao, C., Zhang, Y., Cruz, D., Escamilla, M.A., Li, X., Xu, C., The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS One, 9, 2014, e95875.
139. Yang, X., Han, H., De Carvalho, D.D., Lay, F.D., Jones, P.A., Liang, G., Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell 26 (2014), 577–590.
140. Yehuda, R., Daskalakis, N.P., Bierer, L.M., Bader, H.N., Klengel, T., Holsboer, F., Binder, E.B., Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol. Psychiatry, 2015, 10.1016/j.biopsych.2015.08.005 (in press).
141. Yun, D.H., Pae, C.U., Drago, A., Mandelli, L., De Ronchi, D., Patkar, A.A., Paik, I.H., Serretti, A., Kim, J.J., Effect of the dysbindin gene on antimanic agents in patients with bipolar I disorder. Psychiatry Invest. 5 (2008), 102–105.
142. Zhao, C., Wang, F., Pun, F.W., Mei, L., Ren, L., Yu, Z., Ng, S.K., Chen, J., Tsang, S.Y., Xue, H., Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders. Schizophr. Res. 134 (2012), 260–266.
143. Zhao, H., Xu, J., Pang, L., Zhang, Y., Fan, H., Liu, L., Liu, T., Yu, F., Zhang, G., Lan, Y., Bai, J., Li, X., Xiao, Y., Genome-wide DNA methylome reveals the dysfunction of intronic microRNAs in major psychosis. BMC Med. Genomics, 8, 2015, 62.
144. Zimmermann, N., Zschocke, J., Perisic, T., Yu, S., Holsboer, F., Rein, T., Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels. Biochem. J. 448 (2012), 93–102.